Home > Insider Trading > Filing (0000950170-25-092284)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1768446	Climb Bio Inc.	CLYM	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1714563	Aoife Brennan	C/O Climb Bio, Inc. 20 William Street, Suite 145 Wellesley Hills MA 02481	President And Ceo	No	No	No	No

Transaction Summary

Sold:	20,618 shares	Avg. Price: $1.22	Total Value: $25,153.96
Number of Shares After Transactions:	48,132 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-06-27	68,750	$0.00	68,750	No	4	M	Direct
Common Stock	Disposition	2025-06-30	20,618	$1.22	48,132	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2025-06-27	68,750	$0.00	68,750	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
206,250			No	4	M	Direct

Footnotes

Each restricted stock unit ("RSU") converted into one share of the Issuer's Common Stock.
The sale reported on this Form 4 was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024 to cover tax withholding obligations in connection with the vesting and settlement of the Reporting Person's RSUs.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices within the range of $1.20 to $1.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
The RSUs were granted on June 27, 2024 (the "Grant Date") and are scheduled to vest over four years, with 25% of the shares vesting on each of the first four anniversaries of the Grant Date, subject to the Reporting Person's continued service.